2016
DOI: 10.1016/j.yjmcc.2016.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Permissive role of AMPK and autophagy in adiponectin deficiency-accentuated myocardial injury and inflammation in endotoxemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
35
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 52 publications
(39 citation statements)
references
References 63 publications
4
35
0
Order By: Relevance
“…This may indicate that LPS can stimulate severe autophagy, which is reported in previous studies [27]. A study showed that the a maladaptive role for autophagy in hearts subjected to LPS challenge [28]. Our data suggested that LPS challenge-induced myocardial autophagy is an adaptive response as evidenced by the favorable response from A769662 against LPS-induced cardiac injury which is expected to stimulate AMPK.…”
Section: Discussionsupporting
confidence: 81%
“…This may indicate that LPS can stimulate severe autophagy, which is reported in previous studies [27]. A study showed that the a maladaptive role for autophagy in hearts subjected to LPS challenge [28]. Our data suggested that LPS challenge-induced myocardial autophagy is an adaptive response as evidenced by the favorable response from A769662 against LPS-induced cardiac injury which is expected to stimulate AMPK.…”
Section: Discussionsupporting
confidence: 81%
“…Despite the advance in medical technology and clinical management of sepsis (Ren & Wu, ; Stanzani, Duchen, & Singer, ), targeted therapy is still dismal for septic cardiomyopathy. Evidence from our lab and others has demonstrated a major role for endotoxin lipopolysaccharides (LPS) released from Gram‐negative bacteria in the inflammatory response and cardiovascular homeostasis in sepsis (Pfalzgraff & Weindl, ; Ren et al, ; Zhang et al, ). Although antioxidants (such as metallothionein, insulin‐like growth factor I and catalase), mitochondrial protein aldehyde dehydrogenase (ALDH2) and ER chaperones have shown some promise in the treatment of septic cardiomyopathy (Ceylan‐Isik et al, ; Durand et al, ; Pang, Peng et al, ; Turdi et al, ), clinical validation has not been consolidated for antioxidants and mitochondrial drugs in sepsis and septic hearts.…”
Section: Introductionmentioning
confidence: 99%
“…CD74 is a non‐polymorphic type II transmembrane glycoprotein, participating in T‐cell and B‐cell development, dendritic cell motility and macrophage inflammation in inflammatory diseases including liver fibrosis, diabetes mellitus, systemic lupus erythematosus and Alzheimer disease (Su, Na, Zhang, & Zhao, ). Given the important role of autophagy, oxidative stress and inflammation in septic hearts (Ren et al, ; Sun et al, ; Sun, Cai, & Zang, ), levels of autophagy, O 2 − production, apoptosis and proinflammatory markers were monitored in WT and Cd74 −/− mice challenged with LPS. Levels of key autophagy regulatory molecules including Akt, AMP‐dependent protein kinase (AMPK) and mTOR were evaluated in murine hearts.…”
Section: Introductionmentioning
confidence: 99%
“…Inflammation is a key regulator for autophagy. An increase in autophagy in response to inflammatory signals such as TNF‐α is also well‐known . Yuan et al reported that LPS and TNF‐α both induce autophagy of cardiomyocytes in vitro and in vivo, and enhanced autophagy by rapamycin protect against LPS‐mediated myocyte apoptsosis .…”
Section: Discussionmentioning
confidence: 99%